We are live on ! Find out more
CRL icon

Charles River Laboratories

264 hedge funds and large institutions have $3.54B invested in Charles River Laboratories in 2016 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 111 increasing their positions, 90 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

181% more call options, than puts

Call options by funds: $3.53M | Put options by funds: $1.26M

23% more repeat investments, than reductions

Existing positions increased: 111 | Existing positions reduced: 90

3.94% more ownership

Funds ownership: 96.59%100.53% (+3.9%)

2% less capital invested

Capital invested by funds: $3.61B → $3.54B (-$68.8M)

8% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 38

1% less funds holding

Funds holding: 268264 (-4)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
264
Holders Change
-4
Holders Change %
-1.49%
% of All Funds
7.03%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
35
Increased
111
Reduced
90
Closed
38
Calls
$3.53M
Puts
$1.26M
Net Calls
+$2.27M
Net Calls Change
+$2.85M
Name Holding Trade Value Shares
Change
Change in
Stake
HSBC Holdings
226
HSBC Holdings
United Kingdom
$274K -$444 -6 -0.2%
AP
227
AHL Partners
United Kingdom
$268K -$2.07M -28,006 -89%
BIM
228
Bogle Investment Management
Massachusetts
$249K +$243K +3,289 New
PNC Financial Services Group
229
PNC Financial Services Group
Pennsylvania
$246K +$179K +2,413 +290%
US Bancorp
230
US Bancorp
Minnesota
$236K -$1.26K -17 -0.5%
FIM
231
Freedom Investment Management
Connecticut
$229K +$223K +3,015 New
QIM
232
Quantitative Investment Management
Virginia
$227K +$222K +3,000 New
MPWT
233
MassMutual Private Wealth & Trust
Connecticut
$210K +$8.66K +117 +4%
Envestnet Asset Management
234
Envestnet Asset Management
Illinois
$205K -$1.7K -23 -0.8%
Bessemer Group
235
Bessemer Group
New Jersey
$144K -$1.42M -19,227 -91%
LIA
236
LS Investment Advisors
Michigan
$141K +$10.2K +138 +8%
CG
237
Cutler Group
California
$125K +$120K +1,621 +4,912%
Walleye Trading
238
Walleye Trading
New York
$122K +$54.1K +731 +84%
PAM
239
Paradigm Asset Management
New York
$122K -$229K -3,100 -66%
Zurich Cantonal Bank
240
Zurich Cantonal Bank
Switzerland
$106K
OSAM
241
O'Shaughnessy Asset Management
Connecticut
$104K -$27.1K -366 -21%
NYLT
242
New York Life Trust
New York
$98K -$2.89K -39 -3%
WT
243
Whittier Trust
California
$87K
TRCT
244
Tower Research Capital (TRC)
New York
$87K +$81.3K +1,098 +2,196%
BJ
245
BlackRock Japan
Japan
$80K -$278K -3,751 -78%
IMAS
246
ID Management A/S
Denmark
$76K
EWM
247
Edge Wealth Management
New York
$46K
LTFS
248
Ladenburg Thalmann Financial Services
Florida
$39K -$740 -10 -2%
Geode Capital Management
249
Geode Capital Management
Massachusetts
$23K +$2.39M +32,224 +12%
GAM
250
Gemmer Asset Management
California
$16K

CRL Hedge Fund Activity: Q1 2016 in Review

264 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2016, worth a combined $3.54B — down 1.9% from $3.61B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of CRL and 35 opened new positions — a net loss of 3 holders — while 90 trimmed existing stakes and 111 added.

The largest buyer was Systematic Financial Management, adding an estimated $63.7M. The largest seller was First Trust Advisors, cutting an estimated $88.6M.

  • 264 institutional investors held Charles River Laboratories (CRL) as of Q1 2016, down from 268 in Q4 2015.
  • Funds reported $3.54B of Charles River Laboratories stock for Q1 2016, down 1.9% quarter-over-quarter.
  • 35 funds opened new Charles River Laboratories positions in Q1 2016 and 38 closed out, a net change of -3 holders.
  • The largest Charles River Laboratories buyer in Q1 2016 was Systematic Financial Management, an estimated $63.7M added.
  • The largest Charles River Laboratories seller in Q1 2016 was First Trust Advisors, an estimated $88.6M sold.

Based on aggregated 13F filings for Q1 2016.